Seminars in Oncology Nursing
Volume 23, Issue 3 , Pages 174-183 , August 2007

Prevention of Infection in Patients With Cancer

  • Christopher R. Friese

      Affiliations

    • Corresponding Author InformationAddress correspondence to Christopher R. Friese, RN, PhD, AOCN®, Harvard School of Public Health, 44 Binney St. SM 271, Boston, MA 02115. Fax: (617) 344-0427.

References 

  1. Friese CR. Measuring oncology nursing-sensitive patient outcomes: evidence based summary: prevention of infection. 2004;Available at: www.ons.org/outcomes/measures (accessed December 27, 2006).
  2. Infectious Diseases Society of America. Facts About Infectious Diseases. 2006;Available at: http://www.idsociety.org (accessed January 26, 2006).
  3. Sipsas NV, Bodey GP, Kontoyiannis DP. Perspectives for the management of febrile neutropenic patients with cancer in the 21st century. Cancer. 2005;103:1103–1113
  4. Given BA, Sherwood PR. Nursing-sensitive patient outcomes-a white paper. Oncol Nurs Forum. 2005;32:773–784
  5. National Quality Forum. National voluntary consensus standards for nursing-sensitive care: an initial performance measure set. 2004;Available at: http://www.qualityforum.org/pdf/reports/nsc.pdf (accessed June 22, 2007).
  6. Zitella LJ, Friese CR, Hauser J, et al. Putting evidence into practice: prevention of infection. Clin J Oncol Nurs. 2006;10:739–750
  7. Zitella LJ, Friese CR, Gobel BH, et al. Putting evidence into practice: Prevention of infection. 2006;Available at: www.ons.org/outcomes/volume1/prevention.shtml (accessed June 22, 2007).
  8. Blot F, Nitenberg G. New tools in diagnosing catheter-related infections. Support Care Cancer. 2000;8:287–292
  9. Penwarden LM, Montgomery PG. Developing a protocol for obtaining blood cultures from central venous catheters and peripheral sites. Clin J Oncol Nurs. 2002;6:268–270
  10. Centers for Disease Control and Prevention Hospital Infections Program. National nosocomial infections surveillance system (NNIS) report, data summary from October 1986-April 1996, issued May 1996: a report from the NNIS system. Am J Infect Control. 1996;24:380–388
  11. Gobel BH, Beck SL, O’Leary C. Nursing-sensitive patient outcomes: The development of the putting evidence into practice resources for nursing practice. Clin J Oncol Nurs. 2006;10:621–624
  12. Hadorn DC, Baker D, Hodges JS, et al. Rating the quality of evidence for clinical practice guidelines. J Clin Epidemiol. 1996;49:749–754
  13. In:  Camp-Sorrell D editors. Access device guidelines: recommendations for nursing practice and education. Ed 2.. Pittsburgh, PA: Oncology Nursing Society; 2004;
  14. Infusion Nurses Society. Infusion nursing standards of practice. J Infusion Nurs. 2006;29(suppl 1):S1–S92
  15. Gorski LA. Central venous access device outcomes in a homecare agency: a 7-year study. J Infusion Nurs. 2004;27:104–111
  16. Smith B. Peripheral intravenous catheter dwell times: a comparison of 3 securement methods for implementation of a 96-hour scheduled change protocol. J Infusion Nurs. 2006;29:14–17
  17. Schears GJ. Summary of product trials for 10,164 patients: comparing an intravenous stabilizing device to tape. J Infusion Nurs. 2006;29:225–231
  18. Frey AM, Schears GJ. Why are we stuck on tape and suture? (A review of catheter securement devices). J Infusion Nurs. 2006;29:34–38
  19. Anderson NR. Midline catheters: the middle ground of intravenous therapy administration. J Infusion Nurs. 2004;27:313–321
  20. McDiarmid S, Hamelin L, Huebsch LB. Leading change: retrospective evaluation of a nurse-led initiative in vascular access options for autologous stem cell transplant recipients ranging from Hickman catheters to peripherally inserted central catheters. J Infusion Nurs. 2006;29:81–88
  21. Olson K, Rennie RP, Hanson J, et al. Evaluation of a no-dressing intervention for tunneled central venous catheter exit sites. J Infusion Nurs. 2004;27:37–44
  22. Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection (II. Long-term devices). Clin Infect Dis. 2002;34:1362–1368
  23. O’Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2002;30:476–489
  24. Tablan OC, Anderson JL, Besser R, et al. Guidelines for preventing health care-associated pneumonia, 2003 recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Morb Mortal Wkly Rep. 2003;53(RR03):1–36
  25. Keith DD, Garrett KM, Hickox G, et al. Ventilator-associated pneumonia: improved clinical outcomes. J Nurs Care Qual. 2004;19:328–325
  26. Hinchey JA, Shephard T, Furie K, et al. Formal dysphagia screening protocols prevent pneumonia. Stroke. 2005;36:1972–1976
  27. Boyce JM, Pittet D. Guideline for hand hygiene in health care settings. Am J Infect Control. 2002;30:S1–S46
  28. Sunenshine RH, McDonald LC. Clostridium difficile-associated disease: new challenges from an established pathogen. Cleve Clin J Med. 2006;73:187–197
  29. Boyce JM, Ligi C, Kohan C, et al. Lack of association between the increased incidence of Clostridium difficile-associated disease and the increasing use of alcohol-based hand rubs. Infect Control Hosp Epidemiol. 2006;27:479–483
  30. Garner JS Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol. 1996;17:53–80
  31. Garner JS Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals. 2005;April 1. Available at: http://www.cdc.gov/ncidod/dhqp/gl_isolation.html (accessed December 27, 2006).
  32. Siegel JD, Rhinehart E, Jackson M, et al. Hospital Infection Control Practices Advisory Committee Management of multidrug-resistant organisms in healthcare settings. 2006;Available at: http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf (accessed December 27, 2006).
  33. Shadel BN, Puzniak LA, Gillespie KN, et al. Surveillance for vancomycin-resistant Enterococci: type, rates, costs, and implications. Infect Control Hosp Epidemiol. 2006;27:1068–1075
  34. Young LS, Winston LG. Preoperative use of mupirocin for the prevention of healthcare-associated Staphylococcus aureus infections: a cost-effectiveness analysis. Infect Control Hosp Epidemiol. 2006;27:1304–1312
  35. Wertheim HF, Vos MC, Ott A, et al. Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study. Ann Intern Med. 2004;140:419–425
  36. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med. 2002;136:834–844
  37. Coia JE, Duckworth GJ, Edwards DI, et al. Guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect. 2006;63(suppl 1):S1–S44
  38. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis. 2003;36:131–139
  39. Palmore TN, Sohn S, Malak SF, et al. Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital. Infect Control Hosp Epidemiol. 2005;26:680–684
  40. Modena S, Bearelly D, Swartz K, et al. Clostridium difficile among hospitalized patients receiving antibiotics: a case-control study. Infect Control Hosp Epidemiol. 2005;26:685–690
  41. Bader MS. Staphylococcus aureus bacteremia in older adults: predictors of 7-day mortality and infection with a methicillin-resistant strain. Infect Control Hosp Epidemiol. 2006;27:1219–1225
  42. Asha NJ, Tompkins D, Wilcox MH. Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus. J Clin Microbiol. 2006;44:2785–2791
  43. McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis. 2006;12:409–415
  44. Arango JI, Restrepo A, Schneider DL, et al. Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplant. 2006;37:517–521
  45. Graham PL, Lin SX, Larson EL. A U.S. population-based survey of Staphylococcus aureus colonization. Ann Intern Med. 2006;144:318–325

PII: S0749-2081(07)00052-6

doi: 10.1016/j.soncn.2007.05.002

Seminars in Oncology Nursing
Volume 23, Issue 3 , Pages 174-183 , August 2007

Article Tools

* Image Usage & Resolution